A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Seattle, WA · Spokane, WA · +39 more sites
8 recruiting alzheimer's disease studies with a site in Seattle, WA.
Sponsor: Bristol-Myers Squibb
Seattle, WA · Spokane, WA · +39 more sites
Sponsor: Washington University School of Medicine
Seattle, WA · +7 more sites
Sponsor: Fred Hutchinson Cancer Center
Seattle, WA
Sponsor: Eidos Therapeutics, a BridgeBio company
Seattle, WA · +39 more sites
Sponsor: Washington University School of Medicine
Seattle, WA · +12 more sites
Sponsor: Washington University School of Medicine
Seattle, WA · +12 more sites
Sponsor: Novartis Pharmaceuticals
Seattle, WA · +23 more sites
Sponsor: University of Washington
Seattle, WA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.